ACAD

ACADIA Pharmaceuticals Inc.

15.86 USD
+0.56 (+3.66%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ACADIA Pharmaceuticals Inc. stock is up 4.34% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.38% of the previous 20 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 May 13:44 17 May, 2024 20.00 PUT 140 24
09 May 17:06 17 May, 2024 20.00 PUT 140 24
15 May 14:15 17 Jan, 2025 15.00 CALL 114 14
17 May 14:45 19 Dec, 2025 10.00 CALL 50 15
21 May 14:57 21 Jun, 2024 15.00 CALL 391 609
22 May 15:16 21 Jun, 2024 21.00 PUT 51 85
28 May 16:45 19 Jul, 2024 17.00 CALL 1982 45
30 May 16:16 19 Jul, 2024 16.00 CALL 715 4
18 Jun 15:11 21 Jun, 2024 21.00 PUT 47 81
21 Jun 14:06 19 Jul, 2024 16.00 CALL 403 1248

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.